Replies to post #200150 on Biotech Values

[caravon]

I am not a fan of ENTA’s CEO Jay Luly with his annual compensation over $3M during the last few years.

The ENTA's contract with ABBV is a joke benefiting exclusively Jay Luly and ABBV at an expense of everybody else. Granted their science achievements were/are quite impressive.

[jbog]

Enta's Lay purchase today cost him a whopping $47K. I'm sure he can afford after selling $1.8 mil in stock last year.

This means absolutely nothing.